scholarly journals Ascending aortic aneurysm repair 44 years after Starr–Edwards caged-ball aortic valve replacement

2018 ◽  
Vol 54 (5) ◽  
pp. 962-963
Author(s):  
Gabrielle E Hatton ◽  
Akiko Tanaka ◽  
Anthony L Estrera

Abstract We report a case of ascending aortic aneurysm repair and redo aortic valve replacement with a bioprosthesis 44 years after aortic valve replacement with a Starr–Edwards metal caged-ball prosthesis. The patient presented with a moderately stenotic caged-ball valve and a 50-mm ascending aortic aneurysm on a routine follow-up transthoracic echocardiography. We replaced the valve with a bioprosthesis at the time of aortic repair as the patient wished to stop anticoagulation therapy. Intraoperatively, we found that the cloth covering of the cage was nearly completely destroyed.

Author(s):  
A. Gabriyelyan ◽  
V. Beleyovych ◽  
T. Domansky ◽  
O. Beregovoy ◽  
S. Romanova ◽  
...  

  Introduction. Aortic valve disease is often combined with the ascending aortic aneurysm. According to a number of authors, the frequency of the diagnosis varies from 9 to 50%, and the condition requires one-stage surgical correction. Typically, in these cases, mechanical or biologic prostheses are used. The Ozaki procedure allows such operations to be performed without replacing the aortic valve with an artificial prosthesis. The aim. To analyze the results of aortic valve reconstruction using the Ozaki technique combined with ascending aortic aneurysm repair. Materials and methods. The article describes the first experience of treatment of 12 patients with aortic valve disease and ascending aortic aneurysm. All the patients underwent Ozaki procedure modified by J. Benedik with surgical correction of aneurysm of the ascending aorta and the aortic arch. Results and discussion. No deaths were observed in the postoperative period. There was no conversion to aortic valve replacement. Ultrasound imaging after 3 and 6 months revealed no aortic valve dysfunction. Clinically, patients’ well-being was satisfactory and they returned to normal life. Long-term results of these operations interventions require further study. Conclusions. Our first clinical experience showed promising short- and medium-term results. The indications for aortic valve reconstruction are the same as those for valve replacement with a bioprosthesis. Ozaki procedure can be successfully combined with ascending aortic aneurysm repair. The main advantage is the absence of a frame that does not narrow the opening area of the valve and preserves the aortic root function, which is very important for patients with a narrow aortic root.


2020 ◽  
Vol 35 (8) ◽  
pp. 2033-2034
Author(s):  
Mihaela I. Dregoesc ◽  
Cătălin A. Trifan ◽  
Svetlana Encica ◽  
Wael Halloumi ◽  
Adrian C. Iancu

1995 ◽  
Vol 60 (1) ◽  
pp. 176-180 ◽  
Author(s):  
Paul Simon ◽  
Anton Mortiz ◽  
Reinhard Moidl ◽  
Natascha Kupilik ◽  
Martin Grabenwoeger ◽  
...  

2021 ◽  
Author(s):  
Anirudh Mathur

Background: Aortic root aneurysm involves dilatation of sinuses of Valsalva, sinotubular junction, and proximal ascending aorta. It is a rare complication after aortic valve replacement surgery. A giant aneurysm is defined as an aneurysm of size> 10 cm. Surgical treatment involves Bentall’s procedure. Case Detail: A 40-year-old gentleman with severe aortic regurgitation and moderate aortic stenosis underwent aortic valve replacement with a mechanical prosthetic valve of size 25 mm, 13 years ago. At the time of previous surgery, the ascending aorta was mildly dilated, measured 3.5 cm in size. The patient came with complaints of breathlessness on exertion from the past two months, NYHA class III. Echocardiography and CECT revealed a giant ascending aortic aneurysm about 12.8 cm in diameter with intimal flap suggestive of dissection. Prosthetic valve function and other cardiac structures were assessed as normal. Elective surgery was planned. CPB was established. Ascending aortic aneurysm was excised along with a prosthetic mechanical valve. Bentall’s procedure was done using a 27 mm Dacron composite graft. The patient required a permanent pacemaker for a complete heart block in the postoperative period. Thereafter patient was discharged in stable condition. Conclusion: Aortic aneurysm should be tackled surgically in order to decrease morbidity and mortality. Regular follow-up of such patients should be done.


2021 ◽  
Vol 1 (1) ◽  
Author(s):  
Michael S Trostler

Background: Transcatheter aortic valve replacement is an important procedure with the aging US population presenting with more aortic stenosis and as many as 10 % of these patients presenting with an abdominal aortic aneurysm at the time of screening. This procedure has also been shown to be as safe as open aortic valve replacement with lower risks of death, stroke, and rehospitalization. Case Report: A 91-year-old female presents approximately one month after transcatheter aortic valve with an acute retroperitoneal rupture of a known abdominal aortic aneurysm. The patient was taken for an emergent endovascular aortic aneurysm repair and became suddenly unresponsive and apneic prior to any anesthetic drug administration, the patient was intubated, and rapid transfusion was started. The procedure was completed successfully with immediate improvement in the patient’s vitals after deployment of the stent. The patient was recovering well, but five days later had a sudden pulseless electrical activity arrest and after appropriate but unsuccessful advanced cardiac life support was declared deceased. Conclusion: While not standard of care, a simultaneous endovascular aneurysm repair during transcatheter aortic valve repair in select patients seems to be a safe procedure without increase in complications from either procedure completed separately. The aim of this manuscript is to review the recent success of simultaneous repair and to illustrate that this newer method may improve outcomes.


Heart ◽  
2018 ◽  
Vol 104 (10) ◽  
pp. 814-820 ◽  
Author(s):  
María Del Trigo ◽  
Antonio J Muñoz-García ◽  
Azeem Latib ◽  
Vincent Auffret ◽  
Harindra C Wijeysundera ◽  
...  

ObjectiveTo evaluate the changes in transvalvular gradients and the incidence of valve haemodynamic deterioration (VHD) following transcatheter aortic valve replacement (TAVR), according to use of anticoagulation therapy.Methods and resultsThis multicentre study included 2466 patients (46% men; mean age 81±7 years) who underwent TAVR with echocardiography performed at 12-month follow-up. Anticoagulation therapy was used in 707 patients (28.7%) following TAVR (AC group). A total of 663 patients received vitamin K antagonists, and 44 patients received direct oral anticoagulants. A propensity score matching analysis was performed to adjust for intergroup (AC vs non-AC post-TAVR) differences. A total of 622 patients per group were included in the propensity-matched analysis. VHD was defined as a ≥10 mm Hg increase in the mean transprosthetic gradient at follow-up (vs hospital discharge). The mean clinical follow-up was 29±18 months. The mean transvalvular gradient significantly increased at follow-up in the non-AC group within the global cohort (P=0.003), whereas it remained stable over time in the AC group (P=0.323). The incidence of VHD was significantly lower in the AC group (0.6%) compared with the non-AC group (3.7%, P<0.001), and these significant differences remained within the propensity-matched populations (0.6% vs 3.9% in the AC and non-AC groups, respectively, P<0.001). The occurrence of VHD did not associate with an increased risk of all-cause death (P=0.468), cardiovascular death (P=0.539) or stroke (P=0.170) at follow-up.ConclusionsThe lack of anticoagulation therapy post-TAVR was associated with significant increments in transvalvular gradients and a greater risk of VHD. VHD was subclinical in most cases and did not associate with major adverse clinical events. Future randomised trials are needed to determine if systematic anticoagulation therapy post-TAVR would reduce the incidence of VHD.


Sign in / Sign up

Export Citation Format

Share Document